Please login to the form below
LY-CoV555
This page shows the latest LY-CoV555 news and features for those working in and with pharma, biotech and healthcare.
Independent consultant will review Lilly’s COVID-19 plant issues
The study had been evaluating Lilly’s investigational neutralising antibody bamlanivimab (LY-CoV555) as a treatment for COVID-19 in hospitalised patients, and is sponsored by the US National Institute of
Latest news
-
Eli Lilly’s COVID-19 antibody trial paused due to safety issue
Earlier this month, the drugmaker said that it was seeking initial emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its LY-CoV555 antibody in high-risk
-
Lilly seeks US emergency approval after posting new data for COVID-19 antibodies
The phase 2 study evaluated LY-CoV555 and LY-CoV016, which bind to different regions of the SARS-CoV-2 spike protein, for the treatment of symptomatic COVID-19 in an ... The combination therapy was well tolerated within the study, with no drug-related
-
Eli Lilly begins COVID-19 prevention trial in nursing homes
Eli Lilly has initiated a phase 3 trial of its monoclonal antibody (mAb) LY-CoV555 for the prevention of the novel coronavirus in nursing homes across the US. ... LY-CoV555 is the result of this early screening, and is now the lead candidate from
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Mednet Group
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
